POOR HYGIENE HABITS DRIVES THE ANTIFUNGAL MARKET
Being clean does not mean to be hygienic; there is much more to it. Hygiene can be defined as a number of practices involved in aiding the people in staying healthy. To have a good hygiene has two benefits. Of which one is that it shields people from spreading and catching disease and illness. And another is that is aids to feel pleasant about oneself and the body. Cleanliness is considered as a vital issue. Poor hygiene is not only unhealthy for the person but is also not tolerated by the surrounding. People today have adopted a lifestyle that has tremendously increased the risks of fungal infections which is boosting the demand of the anti-fungal market.
Today, every other person is infected with some or the other fungal infection. Evolvement of drug resistance, healthcare policies, programs and initiatives taken by the government are some of the factor responsible for the growth of the anti-fungal agents market. The increase in the poor hygiene habits Increase in the number of patients that are suffering from the infectious disease due to improper hygiene generally in the developing countries are the main reason for the increase in the anti-fungal market.
Infants and generic population are more prone to fungal infections. Bathing regularly, brushing hair, proper grooming of oral health, are some of the habits that reduce the threat of bacteria that are constantly residing in our body. Wounds on the children bodies should be cleaned thoroughly as they contain a huge amount of bad bacteria that can lead severe damage to the part being hurt or left untreated. Also, people who have a chronic illness like diabetes must be more thoughtful of injuries as these diseases tend to slow down the healing ultimately, leading to harmful fungal infections. Pregnant women must also take precautions as their bodies are prone to catching infection which can sometimes affect the infant while giving birth. Researchers have also mentioned that some anti-fungal drugs are not prescribed to pregnant women which act as a restraint to the anti-fungal drug market.
Topical drug application is the highest revenue generating application in the anti-fungal agents market. The topical drugs are in a varied form consisting pastes, powder, ointments, etc. These medications are applied directly to the infected part of the body or on the skin. Topical drugs generally have sophisticated effects, although, mishandling can lead to complications. Growth in the incidence of fungal infections, the evolvement of novel antifungal biopharmaceuticals, the tremendous investment made in the drug production, government initiatives concerning fungal infections has made North America hold the colossal share in the anti-fungal market.
Top companies that led the anti-fungal agent market are Johnson & Johnson, Novartis, and Pfizer, Astellas Pharma Inc., Teva pharma. Among all Astellas Pharma is the highest in the terms of market capitalization and production. High demand for anti-fungal products is responsible for the growth of the global anti-fungal market. The latest trend in the antifungal agents market adopted by the companies to achieve more market share is varied strategic initiatives.